Navigation Links
Bioness Inc Announces Availability of L300 Plus System
Date:8/29/2011

VALENCIA, Calif., Aug. 29, 2011 /PRNewswire/ -- Bioness Inc., today announced the commercial release of its NESS L300® Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300® Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.

The L300 Plus is intended for people living with neurological conditions resulting from stroke, multiple sclerosis, traumatic brain injury and spinal cord injury. The L300 Plus also helps to facilitate muscle re-education, prevent muscle atrophy, increase range of motion and increase local blood flow.

Sheltering Arms Physical Rehabilitation Centers located in Richmond, Va. is the first rehabilitation center in the country to offer the L300 Plus. According to James E. Sok, President and CEO, "The L300 Plus is a welcomed addition to our iWalk program which empowers our patients by offering a wide-range of technology-based therapy solutions. We are excited to offer leading rehab technologies in combination with our highly trained therapists to help restore function in our patients as they reintegrate back into the community."  

"For individuals living with central nervous system disorders, lack of mobility can be a challenging and life-altering issue," said Todd Cushman, Senior Vice President of Global Sales, Business Development and Marketing for Bioness. "With the L300 Plus, we aim to provide the more than 150,000 physical therapists and 3,200 neurorehabilitation clinics in the United States another option for helping neurological patients with gait disorders."

The L300 Plus is now commercially available to neurorehabilitation hospitals and centers around the country, and to consumers for home use.

For more information about the Bioness L300 Plus System and other Bioness devices, please call 800.211.9136 Option 2, or visit www.bioness.com.

About Bioness Inc.

Bioness provides neuromodulation technologies that help improve lives and restore function for those living with neurological deficits and peripheral pain. The Company designs and markets innovative neuromodulation products that help individuals with central nervous system disorders such as stroke, multiple sclerosis, spinal cord injury and traumatic brain injury regain movement in affected limbs. The NESS L300® Foot Drop System, NESS H200® Hand Rehabilitation System, and NESS L300® Plus System are cleared for use by the Food and Drug Administration and may help patients achieve new levels of physical independence and productivity.

Individual results vary. Consult with a qualified physician to find out if these products are right for you. Additional information about Bioness can be found at www.bioness.com.

NESS®, NESS H200®, NESS L300®, NESS L300® Plus, Bioness® are trademarks of Bioness Inc. | www.bioness.com | Rx Only

Media Contact:

Wendy Ryan/Genevieve Gadenne
Schwartz Communications
781-684-0770
bioness@schwartzcomm.com


'/>"/>
SOURCE Bioness Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioness Inc. Receives FDA Clearance of Its NESS L300 Plus System
2. Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program
3. Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
4. Masters Pharmaceutical, Inc. Announces DEA Registration for New Distribution Center
5. Life Extension® Announces Recruitment for Alzheimers Clinical Trial in South Florida
6. PDI Announces Renewal of Engagement for 7th Consecutive Season
7. Nutrastar Announces Adoption of Share Repurchase Program
8. ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
9. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock
10. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
11. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology:
(Date:9/23/2017)... ... September 23, 2017 , ... Silicon Valley Hair Institute, the leading ... new blog post focused on the ARTAS® hair transplant system and the younger demographic. ... the latest, most technologically sophisticated methods of hair restoration. , “It can be emotionally ...
(Date:9/22/2017)... Plano, TX (PRWEB) , ... September 22, 2017 , ... ... created to strengthen the communities they serve as part of the nationally recognized ‘Agents ... by working closely with nonprofit organizations and community leaders to seek out those who ...
(Date:9/22/2017)... ... 22, 2017 , ... Happy Living’s mission - to improve the health and ... the entertaining and delicious worlds of theatre and wines. , After watching Scott ... to turn his play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ) ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... host Rob Lowe, explores the world of Alzheimer’s. Alzheimer’s is a disease estimated ... disease. This according to information published by the Alzheimer’s Association, a leading voice ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg freezing and embryo freezing ... have a slight statistical advantage for live births, frozen eggs offer many advantages, ... women undergoing medical treatment or who are concerned about the decline of their ...
Breaking Medicine News(10 mins):